Wildcat Capital Management, LLC - Q1 2022 holdings

$391 Million is the total value of Wildcat Capital Management, LLC's 25 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 37.5% .

 Value Shares↓ Weighting
SKLZ  SKILLZ INC$64,896,000
-59.7%
21,632,1570.0%16.60%
-36.6%
RLX BuyRLX TECHNOLOGY INCsponsored ads$55,299,000
-40.5%
30,893,022
+29.6%
14.15%
-6.6%
CSGP SellCOSTAR GROUP INC$30,353,000
-27.3%
455,685
-13.8%
7.77%
+14.2%
GSHD  GOOSEHEAD INS INC$28,025,000
-39.6%
356,6830.0%7.17%
-5.1%
MSP BuyDATTO HLDG CORP$26,132,000
+21.4%
978,007
+19.7%
6.69%
+90.7%
TDG  TRANSDIGM GROUP INC$23,044,000
+2.4%
35,3680.0%5.90%
+60.9%
FB  META PLATFORMS INCcl a$23,026,000
-33.9%
103,5530.0%5.89%
+3.9%
BKNG SellBOOKING HOLDINGS INC$19,753,000
-42.9%
8,411
-41.6%
5.05%
-10.2%
LBRDK SellLIBERTY BROADBAND CORP$19,522,000
-38.7%
144,265
-27.0%
5.00%
-3.6%
ALLO BuyALLOGENE THERAPEUTICS INC$19,389,000
-24.3%
2,128,370
+24.0%
4.96%
+19.0%
CNSL BuyCONSOLIDATED COMM HLDGS INC$16,977,000
-8.0%
2,877,447
+16.7%
4.34%
+44.7%
CPNG SellCOUPANG INCcl a$15,202,000
-56.9%
859,817
-28.4%
3.89%
-32.3%
FYBR NewFRONTIER COMMUNICATIONS PARE$13,711,000495,525
+100.0%
3.51%
GPN  GLOBAL PMTS INC$10,939,000
+1.2%
79,9410.0%2.80%
+59.0%
KRON  KRONOS BIO INC$10,398,000
-46.8%
1,438,2320.0%2.66%
-16.4%
URGN  UROGEN PHARMA LTD$4,644,000
-8.4%
533,1390.0%1.19%
+43.8%
DDOG BuyDATADOG INC$3,020,000
+27.3%
19,935
+49.6%
0.77%
+100.3%
 NERDY INC$2,788,000
+13.1%
547,8000.0%0.71%
+77.8%
MQ NewMARQETA INC$1,412,000127,871
+100.0%
0.36%
NewVACASA INC$827,000100,000
+100.0%
0.21%
OYST  OYSTER PT PHARMA INC$429,000
-36.3%
36,8470.0%0.11%0.0%
DOCN NewDIGITALOCEAN HLDGS INC$382,0006,596
+100.0%
0.10%
SNOW SellSNOWFLAKE INCcl a$362,000
-85.0%
1,578
-77.9%
0.09%
-76.4%
NewROBINHOOD MKTS INC$187,00013,876
+100.0%
0.05%
 NERDY INC*w exp 08/16/202$120,000
+33.3%
99,6000.0%0.03%
+106.7%
INTU ExitINTUIT$0-769
-100.0%
-0.08%
FIGS ExitFIGS INCcl a$0-21,207
-100.0%
-0.10%
SPCE ExitVIRGIN GALACTIC HOLDINGS INC$0-75,645
-100.0%
-0.16%
PCOR ExitPROCORE TECHNOLOGIES INC$0-22,869
-100.0%
-0.30%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
COSTAR GROUP INC32Q3 202248.3%
UROGEN PHARMA LTD26Q3 202317.3%
META PLATFORMS INC26Q3 20239.9%
ALLOGENE THERAPEUTICS INC18Q3 202322.4%
GOOSEHEAD INSURANCE INC -A18Q3 202315.4%
SABINE RTY TRUST18Q3 202111.3%
LPL FINL HLDGS INC18Q1 201912.7%
PLAYA HOTELS & RESORTS NV18Q3 20213.4%
NANTKWEST INC17Q3 201922.0%
SORRENTO THERAPEUTICS INC17Q2 20197.0%

View Wildcat Capital Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Wildcat Capital Management, LLC Q1 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Skillz Inc.January 05, 202319,596,9885.6%
UroGen Pharma Ltd.February 14, 2022533,1392.4%
Skillz Inc.March 08, 202121,832,0227.5%
NantKwest, Inc.February 13, 2018808,9741.0%
Sorrento Therapeutics, Inc.February 13, 20181,738,2322.2%

View Wildcat Capital Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR2023-11-09
PX14A6G2023-11-03
13F-HR2023-08-11
13F-HR/A2023-08-10
13F-HR2023-05-12
13F-HR2023-02-07
SC 13D/A2023-01-05
13F-HR2022-11-08
13F-HR/A2022-11-08

View Wildcat Capital Management, LLC's complete filings history.

Compare quarters

Export Wildcat Capital Management, LLC's holdings